Cobalamin (Cbl) utilization as a cofactor for methionine synthase and methylmalonyl-CoA mutase is dependent on the transport of Cbl through lysosomes and its subsequent delivery to the cytosol and mitochondria. We speculated that neuropathological conditions that impair lysosomal function (e.g., agerelated lipofuscinosis and specific neurodegenerative diseases) might impair lysosomal Cbl transport. To address this question, an appropriate method to quantify intracellular Cbl transport in neuronal cell types and brain tissue is required. Thus, we developed methods to measure [ 57 Co] Cbl levels in lysosomes, mitochondria and cytosol obtained from in vitro and in vivo sources. Human SH-SY5Y neurons or HT1080 fibroblasts were labeled with [ 57 Co] Cbl and homogenized using a ball-bearing homogenizer, and the lysates were separated into 10 fractions using ultracentrifugation in an OptiPrep density gradient. Lysosomes were recovered from the top of the gradient (fractions 1-5), which were clearly separated from mitochondria (fractions 7-9) on the basis of the expression of the marker proteins, LAMP2 and VDAC1. The isolated lysosomes were intact based on their colocalization with acid phosphatase activity. The lysosomal and mitochondrial fractions were free of the cytosolic markers beta-actin and methionine synthase. The relative distribution of [ 57 Co] Cbl in both neurons and fibroblasts was as follows: 6% in the lysosomes, 14% in the mitochondria and 80% in the cytosol. This technique was also used to fractionate organelles from mouse brain, where marker proteins were detected in the gradient at positions similar to those observed for the cell lines, and the relative distribution of [ 57 Co] Cbl was as follows: 12% in the lysosomes, 15% in the mitochondria and 73% in the cytosol. These methods provide a useful tool for the investigation of intracellular Cbl trafficking in a neurobiological setting. fractions using ultracentrifugation on an OptiPrep density gradient. Lysosomes were recovered at the top of the gradient (fractions 1 to 5) and were clearly separated from mitochondria (fractions 7 to 9) based on marker proteins LAMP2 and VDAC1, respectively.
Abstract
Cobalamin (Cbl) utilization as a cofactor for methionine synthase and methylmalonyl-CoA mutase is dependent on its transit through lysosomes and subsequent delivery to cytosol and mitochondria. We speculate that neuropathological conditions that impair lysosomal function (e.g. age-related lipofuscinosis and certain neurodegenerative diseases) may impair lysosomal Cbl transport. To study this question, an appropriate method to quantify intracellular Cbl transport in neuronal cell types and brain tissue is required. We therefore developed methods to measure [
57 Co]Cbl levels in lysosomes, mithochondria and cytosol derived from in vitro and in vivo sources. Human SH-SY5Y neurons or HT1080 fibroblasts were labelled with [ 57 Co]Cbl, homogenised using a ball-bearing homogenizer, and the lysates separated into 10 fractions using ultracentrifugation on an OptiPrep density gradient. Lysosomes were recovered at the top of the gradient (fractions 1 to 5) and were clearly separated from mitochondria (fractions 7 to 9) based on marker proteins LAMP2 and VDAC1, respectively.
The isolated lysosomes were intact based on colocalisation with acid phosphatase activity.
The lysosomal and mitochondrial fractions were free of cytosolic markers beta-actin and methionine synthase. The relative distribution of [ lysosomes 12%, mitochondria 15% and cytosol 73%. These methods provide a useful tool for investigating intracellular Cbl trafficking in a neurobiology setting.
Introduction
Cobalamin (Cbl) 1 is required for erythrocyte formation and DNA synthesis, and plays a crucial role in the maintenance of neurological function. Methyl Cbl (MeCbl) and adenosyl Cbl (AdoCbl) are the forms that are active in human metabolism. These two forms of Cbl differ only in the functional group attached to the Co atom at the centre of the Cbl corrin ring.
MeCbl is used to transform homocysteine (Hcy) to methionine (Met) via cytosolic methionine synthase (MS). This reaction requires donation of a methyl group derived from the transformation of 5-methyltetrahydrofolate (5-methyl-THF) to tetrahydrofolate (THF).
Through the action of methionine adenosyltransferase, Met is utilized in the formation of Sadenosylmethionine (SAM), a universal methyl donor for numerous substrates, including DNA, RNA, hormones, proteins, and lipids. AdoCbl is required for the conversion of methylmalonyl-coenzyme A (Mm-CoA) to succinyl-coenzyme A (Succ-CoA) via mitochondrial Mm-CoA mutase (MMCM). Succ-CoA then enters the Krebs cycle, after which it may be utilized in many pathways including conversion to succinate which may be used as an electron donor or in the synthesis of porphyrins such as haeme.
MS and MMCM activities are reduced in human Cbl deficiency states, causing increased tissue and plasma Hcy levels and, subsequent to the conversion of Mm-CoA to methylmalonic acid (MMA), increased tissue and plasma MMA levels. Because of the roles of both MS and MMCM in methylation reactions and multiple pathways related to, for example, amino acid and lipid metabolism, the clinical Cbl deficiency phenotypes are multifaceted (Baik and Russell, 1999) . In addition to the "loss of function" caused by impaired MS and MMCM activities, the accumulation of Hcy and MMA is neurotoxic and is thought to contribute to neurodegeneration and loss of cognitive capacity (Kolker et al., 2000; Morris, 2003) .
Cbl utilization is dependent on its transit through the intracellular lysosomal compartment (Banerjee et al., 2009; Gailus et al., 2010; Zhao et al., 2011) . We have recently proposed that pathophysiological impairment of lysosomal functions that occur in various conditions such as Alzheimer's disease, lysosomal storage disorders and in age-related neuronal lipofuscinosis may form a "road block" for efficient Cbl utilization in cells. We predict that these conditions may impair the release Cbl from its carrier protein transcobalamin-II (TCII) and inhibit the transport of lysosomal Cbl to both MS and MMCM (Zhao et al., 2011) . In addition, it is known that the acidic pH of the lysosome also influences the conversion of Cbl from the "base-on" to "base-off" state, which refers to the interaction of the dimethylbenzimidazole moiety of the Cbl molecule with the central Co atom (Banerjee, 2006 
Cell homogenization
A lysosome enrichment kit (Pierce, Cat #89839, USA) was applied to perform subcellular fractionation. An 800 μl aliquot of extraction buffer Lysosome Enrichment Reagent (LER) "A" containing 1% protease inhibitors was added to the cell pellets. The pellets were gently re-suspended and incubated on ice for no more than 2 minutes. The cell suspension was transferred to a ball-bearing cell homogenizer (Isobiotec, Germany) and homogenized on ice.
To check lysis efficiency, 10 μl of cell lysate was stained with 0.5% trypan blue and viewed under a light microscope. Homogenization was continued until 95% cell membrane breakage was achieved (typically 10 to 15 passages through the homogenizer). Next, the lysed cells were transferred into a 2 ml microcentrifuge tube and 800 μl of LER "B" containing 1%
protease inhibitors was mixed with the lysed cells. The mixed cell lysates were centrifuged at 600 g for 10 min at 4˚C to remove nuclei and membranous debris and the supernatant (1500 l) containing lysosomes, mitochondria and cytosol was collected.
Density gradient ultracentrifugation
To prepare a discontinuous density gradient, five gradient solutions were prepared by mixing gradient dilution buffer (a 1:1 mixture of LER A and LER B) with the OptiPrep medium (that is supplied as a 60% solution in H 2 O) as described in Table 1 . The diluted OptiPrep density gradient solutions were carefully overlayed in descending concentration order (i.e. 30%
OptiPrep solution first and then 27%, 23%, 20% and 17%) in a 7 ml ultracentrifuge tube (Hitachi Koki, Japan). Next, the prepared 1500 μl supernatants from the cell extracts described above were mixed with 500 μl of OptiPrep medium to make a final concentration of 15% OptiPrep and this was overlayed on the top of the density gradient. The tube was centrifuged at 145,000 g for 4 h at 4˚C using a Sorvall MTX 150 ultracentrifuge and a Sorvall S50ST swinging bucket rotor (Thermo Scientific). After centrifugation, two distinct bands appeared in the gradient solution ( 
Western blotting
To identify the fractions containing lysosomes, mitochondria, and cytosol, western blotting was performed with appropriate antibodies to marker proteins; lysosome, lysosomalassociated membrane protein 2 (LAMP2, Southern Biotech); mitochondria, voltagedependent anion channel 1 (VDAC1, Abcam); cytosol, β-actin (Sigma) and methionine synthase / 5-methyltetrahydrofolate-homocysteine methyltransferase (MS, Abnova). Briefly, sample proteins from each fraction were separated on 12% SDS PAGE gels using a MiniProtean II system (Bio-Rad) at 150 V for 70 minutes followed by transfer at 100 V for 30 min onto 0.45 m nitrocellulose membranes using a Mini-Trans-Blot Electrophorectic
Transfer cell (Bio-Rad). The membranes were blocked in 5% (w/v) non-fat milk powder in PBS for 1 h at 22˚C and then probed with anti-LAMP2 mouse monoclonal antibody (1:4000),
anti-VDAC1 rabbit polyclonal antibody (1:4000), anti-β-actin rabbit polyclonal antibody
(1:10000), and anti-MS goat polyclonal antibody (1:300) at 4°C for 16 h, followed by incubation with the appropriate horseradish-peroxidase-conjugated rabbit anti-mouse
(1:4000, Dako), goat anti-rabbit (1:4000, Dako), and rabbit anti-goat (1:4000, Dako) IgG antibodies for 1 h at 22˚C. Blots were rinsed in PBS and proteins were detected using enhanced chemiluminescence (ECL, Amersham Biosciences). The membranes were exposed to X-ray film (Fuji), developed, scanned and signal intensity was quantified using NIH Image software.
Acid phosphatase assay
During cell homogenization and ultracentrifugation, lysosome membranes are susceptible to pressure and may be broken, thus lysosomal hydrolases may be leaked into the cytosol as a consequence. Acid phosphatase is one of the acid hydrolases that exist in lysosomes and therefore is a classical marker for the identification of lysosomes in subcellular fractionation studies. The acid phosphatase assay kit (Sigma, Cat #CS0740) was applied to detect lysosome membrane integrity in each fraction. Briefly, a substrate solution was prepared by dissolving one 4-nitrophenyl phosphate tablet in 5 ml of citrate buffer and the solution equilibrated at 37˚C. The standard solution was prepared by diluting 5 µl of the 10 mM nitrophenol standard solution in 995 µl of 0.5 M NaOH. The reaction components and samples were added to 96-well microtitre plates according to the manufacturer's instructions and samples analysed in triplicate. The plate was incubated for 10 min at 37˚C after which time 200 µl of 0.5 M NaOH was added to all wells (except the standard) to stop the reaction.
Absorption was measured at 405 nm using a microtitre plate reader (Spectra Max, Bio Strategy) and results expressed as acid phosphatase Units / ml (where 1 Unit of enzyme activity will hydrolyse 1 mole of 4-nitrophenyl phosphate per min at pH 4.8 at 37˚C). Co]cyanoCbl in a volume of 0.2 ml sterile saline (0.9% w/v NaCl). The mice were weighed at time of injection and again just before sacrifice. After 72 h the mice were sacrificed and the blood samples were collected by cardiac puncture. The mice were then transcardially perfused with PBS and the brain, liver and kidney were dissected. All organs were weighed and the amount of [ 57 Co]Cbl in these organs was measured using a gamma counter. In this experiment, only the brain was used for organelle isolation. The brain was rinsed with PBS and cut into small pieces (< 3 mm 3 ). The procedures for homogenization and subcellular fractionation were the same as described above for cultured cells.
Animal study

Data analysis
Data are presented as mean ± SE of three independent experiments unless stated otherwise. 
Results
Method overview
Cbl exists in three main compartments in the cell: the lysosome, mitochondria and cytosol. In order to accurately assess Cbl transit through intracellular compartments, it is essential to develop methods that can separate at least these three compartments into fractions in which labeled Cbl can be unambiguously quantified. We therefore used the following steps to achieve this: (1) cells were labeled with [ 57 Co]Cbl; (2) cells were disrupted in a ball-bearing homegnizer, (3) the isolated organelles were separated from cellular membrane debris and nuclei, (4) the organelles were separated over an OptiPrep density gradient by ultracentrifugation, (5) ten fractions were collected from the gradient, and (6) the fractions were separated into pellet (organelle) and supernatant (cytosol) fractions. The methodological detail for each of these steps is described in "Materials and Methods" and an overview is illustrated in Figure 1 . The purified fractions were then analysed for various organelle markers and for [ 57 Co] radioactivity.
Isolation of lysosomes, mitochondria and cytosol from fibroblasts
Our initial experiments focused on the HT1080 human fibroblast cell line. Western blot analysis of the organelle fractions for LAMP2 and VDAC1 (lysosomal and mitochondrial markers, respectively) revealed lysosomes were recovered from the top of the OptiPrep gradient, especially in Fraction 1 (Fig. 2A) . As LAMP2 was also detected at lower levels in
Fractions 2 to 5, these fractions together (Fractions 1 to 5) were considered to represent the lysosomal content of the cells. In contrast, VDAC1 was detected in Fractions 7 to 9 and thus represented the mitochondrial fractions. It is noteworthy that -actin was detected at very low levels, if at all, in the isolated organelle fractions, and MS was not detected in any of the organelle fractions ( Fig. 2A) . This indicates that pure lysosomes can be separated from mitochondria and that both organelles are essentially free of cytosolic contaminants that may spuriously contribute to apparent organelle Cbl levels.
The cytosolic components of each of the ten OpitPrep gradient fractions were also assessed by western blotting. Neither LAMP2 nor VDAC1 were detected in the cytosolic fractions, whereas -actin was clearly detected in Fractions 1 to 8, with particularly high levels in Fractions 1 to 4 (Fig. 2B ). In addition, MS was detected in Fractions 1 to 3, with particularly high levels in Fraction 2.
Isolation of lysosomes, mitochondria and cytosol from neurons
We also used the same method to purify lysosomes and mitochondria from the human SH-SY5Y neuronal cell line. Similar to the results derived from our fibroblast studies, pure lysosomal and mitochondrial preparations were recovered from Fractions 1 to 5 and from Fractions 7 to 9, respectively (Fig. 3A) . Neither -actin nor MS were detected in the organelle fractions (Fig 3A) . Assessment of the cytosolic fractions revealed there was no contamination of cytosol with lysosomes or mitochondria, as assessed by lack of signal for LAMP2 and VDAC1, respectively (Fig. 3B) . Moreover, -actin was clearly detected in Fractions 1 to 9, with particularly high levels in Fractions 1 to 6, whereas MS was detected in predominantly Fractions 2 to 5 (Fig. 3B ).
The methods we describe can therefore be used to isolate pure lysosomal, mitochondrial and cytosolic preparations from fibroblasts and neurons.
Confirmation that isolated lysosomes remain intact after purification
To confirm that the isolated lysosomes remained intact during the homogenization and ultracentrifugation procedures, we assessed all organelle and cytosolic fractions for acid phosphatase activity. The data indicate that acid phosphatase activity correlated with the expression of LAMP2 in the lysosomal fractions from both fibroblasts and neurons ( Fig 4A and 4B, respectively). Furthermore, acid phosphatase activity was not detected in any of the cytosolic fractions (Fig 4) . This indicates that lysosomes remain structurally intact during the isolation procedures and that the lysosomal membranes are not compromised. Note that the buffers used in the acid phosphatase assay were adjusted to pH 4.8 so that even if the enzyme was located in the cytosol (normally close to neutral pH) we would still detect its activity in the 4-nitrophenyl phosphate hydrolysis assay.
Subcellular [ 57
Co]cobalamin distribution in fibroblasts and neurons
Having established methods for the isolation of pure lysosomes, mitochondria and cytosol, and shown that the lysosomes maintain their structural integrity, we next assessed the We then subjected the whole brain to the subcellular fractionation method developed above.
Highly purified lysosomal and mitochondrial preparations that were essentially free of -actin were recovered from Fractions 1 to 4 and from Fractions 7 to 9, respectively (Fig. 6A) .
Analysis of the mouse brain cytosolic fractions indicated a strong signal for -actin in Fractions 1 to 5 and no contamination with either LAMP2 or VDAC1 (Fig. 6B ). Similar to the data derived from cultured cells, acid phosphatase activity colocalised predominatly in the LAMP2-positive fractions (Fig. 6C) . Finally, the relative distribution of [ lysosomes 12%, mitochondria 15%, and cytosol 73% (Fig. 6D ).
Discussion
In the present work we have successfully developed a [ (Hannibal et al., 2008; Mellman et al., 1978; Yamani et al., 2008; Yassin et al., 2000; Youngdahl-Turner et al., 1978) or aspects of lysosome function in cells and mice (Manunta et al., 2007; Yang et al., 2011) . Our data and in mouse models of ageing and neurodegenerative disease.
We also noted that in the subcellular fractionation of the brain tissue, a small increase in acid phosphatase activity was present with the major mitochondrial fraction (Fraction 8). We did not detect LAMP2 in this fraction so lysosomal contamination seems unlikely. One possible explanation could be that one or more of the several known mitochondrial phosphatases may have residual activity at pH 4.8 and thus act upon the 4-NPP is our assay (McBride et al., 2006) .
The critical role that the lysosome plays in delivery of Cbl to MS in the cytosol and MMCM in the mitochondrion is demonstrated by the inborn error of Cbl metabolism referred to as cblF. This life-threatening condition is caused by defects in the LMBRD1 gene that encodes LMBD1 (Rutsch et al., 2009) . The defect in lysosomal Cbl release was discovered 25 years ago, well before the likely transporter involved was characterised (Rosenblatt et al., 1985) .
These pioneering studies also showed that chloroquine, a compound that increases lysosomal pH above its physiological level of ~ 4.5 thereby inhibiting lysosomal protease activity, prevents the release of Cbl from TCII and blocks the transport of lysosomal [ 57 Co]Cbl to both MS and MMCM (Rosenblatt et al., 1985) . We have recently hypothesized that in addition to LMBRD1 mutations and drug-mediated alterations of lysosomal function that may trap Cbl in the lysosome, additional pathophysiological perturbations in lysosome function could also represent a "roadblock" for Cbl transit through the lysosomal compartment (Zhao et al., 2011) . Future studies could utilize the methods we have established herein to assess cell lines and animals models that are known to have impaired lysosome function due to, for example, accumulation of the age pigment lipofuscin, substrate accumulation in various lysosomal storage diseases, or accumulation of -amyloid (Zhao et al., 2011) . Based on the fact that Cbl deficiency includes a neurological phenotype (Baik and Russell, 1999; Calvaresi and Bryan, 2001; Healton et al., 1991) (Graham, 2001; Koenig, 1974; Yamada et al., 1984) ) may yield similar results.
Conclusions
We have established a subcellular fractionation method that provides a useful tool for 
